Puma Biotechnology, Inc.

PBYI · Healthcare · Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care…

Puma Biotechnology, Inc. (PBYI), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 5 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 14 and filed Sep 17. The most active filer was Alan H Auerbach with 3 filings.

Add to watchlist

Filings, ttm

0 buys · 5 sells

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$1.4M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 14

Filed Sep 16

ADViAverage daily dollar volume

$2.9M

market data

Share price · 12M

$9.60 (+115.2%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $1.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Alan H Auerbach President and CEO 3 filings AC

Alessandra Cesano Director 1 filing JM

Jay M Moyes Director 1 filing AS

Adrian Senderowicz Director 1 filing

Recent filings

Alessandra CesanoSALE Director $567K
62,150 sh × $9.12
Exec Sep 14
Filed Sep 16 · 9:06 PM ET Alan H AuerbachSALE President and CEO $364K
44,058 sh × $8.26
Exec Jul 6
Filed Jul 8 · 8:21 PM ET Jay M MoyesSALE Director $159K
22,000 sh × $7.22
Exec Jun 12
Filed Jun 15 · 5:30 PM ET Adrian SenderowiczSALE Director $194K
27,000 sh × $7.20
Exec Jun 12
Filed Jun 15 · 5:30 PM ET Alan H AuerbachSALE President and CEO $106K
18,012 sh × $5.88
Exec Jan 7
Filed Jan 8 · 5:30 PM ET Alan H AuerbachSALE President and CEO $107K
33,841 sh × $3.15
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET